Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Abraham AG, Guo X, Arsiwala LT, et al. "Cognitive decline in older adults: What can we learn from optical coherence tomography (OCT)-based retinal vascular imaging?" J Am Geriatr Soc. 2021;69(9):2524-2535.
Naorungroj S, Slade GD, Beck JD, Mosley TH, Gottesman RF, Alonso A. "Cognitive decline and oral health in middle-aged adults in the ARIC study." J Dent Res. 2013;92(9):795-801.
Schneider ALC, Gottesman RF, Mosley T, et al. "Cognition and incident dementia hospitalization: results from the atherosclerosis risk in communities study." Neuroepidemiology. 2013;40(2):117-24.
West NA, Johnson DA, Lutsey PL, Mosley TH, Redline S. "Cognition and 20-year subsequent sleep disturbances." Sleep Health. 2021.
Nettleton JA, Follis JL, Schabath MB. "Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2009;169(12):1445-53.
Nieto FJ, Comstock GW, Chambless LE, Malinow RM. "Coffee consumption and plasma homocyst(e)ine: results from the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 1997;66(6):1475-7.
Hu EA, Lazo M, Selvin E, et al. "Coffee consumption and liver-related hospitalizations and deaths in the ARIC study." Eur J Clin Nutr. 2019;73(8):1133-1140.
Hu EA, Selvin E, Grams ME, Steffen LM, Coresh JJ. "Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2018;72(2):214-222.
Paynter NP, Yeh H-C, Voutilainen S, et al. "Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study." Am J Epidemiol. 2006;164(11):1075-84.
Cushman M, O'Meara ES, Folsom AR, Heckbert SR. "Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology." Blood. 2009;114(14):2878-83.
Tsai AW, Cushman M, Rosamond WD, et al. "Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)." Am J Med. 2002;113(8):636-42.
Yamagishi K, Aleksic N, Hannan PJ, Folsom AR. "Coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease." J Atheroscler Thromb. 2010;17(4):402-9.
Schmidt MI, Watson RL, Duncan BB, et al. "Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators." Metabolism. 1996;45(6):699-706.
Mok Y, Ishigami J, Sang Y, et al. "Clinically recognized varicose veins and physical function in older individuals: the ARIC study." J Gerontol A Biol Sci Med Sci. 2021.
Wattanakit K, Folsom AR, Duprez DA, Weatherley BD, Hirsch AT. "Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2007;190(2):459-64.
Chamberlain AM, Agarwal SK, Folsom AR, et al. "A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)." Am J Cardiol. 2011;107(1):85-91.
Yang EY, Nambi V, Tang Z, et al. "Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study." J Am Coll Cardiol. 2009;54(25):2388-95.
Chunawala ZS, Fudim M, Arora S, et al. "Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study)." Am J Cardiol. 2021.
Rosamond WD, Chang PP, Baggett C, et al. "Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria." Circ Heart Fail. 2012;5(2):152-9.
Loehr LR, Agarwal SK, Baggett C, et al. "Classification of acute decompensated heart failure: an automated algorithm compared with a physician reviewer panel: the Atherosclerosis Risk in Communities study." Circ Heart Fail. 2013;6(4):719-26.
Hui X, Matsushita K, Sang Y, Ballew SH, Fulop T. "CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race." Am J Kidney Dis. 2013;62(4):691-702.
Hoogeveen RC, Ballantyne CM, Bang H, et al. "Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study." Diabetologia. 2007;50(1):36-42.
Georgakis MK, Malik R, Björkbacka H, et al. "Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals." Circ Res. 2019;125(8):773-782.
Alonso A, Misialek JR, Amiin MA, et al. "Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort." Heart. 2014;100(19):1511-6.
Alonso A, Misialek JR, Eckfeldt JH, et al. "Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study." J Am Heart Assoc. 2014;3(5):e001082.
Alonso A, Rooney MR, Chen LYee, et al. "Circulating electrolytes and the prevalence of atrial fibrillation and supraventricular ectopy: The Atherosclerosis Risk in Communities (ARIC) study." Nutr Metab Cardiovasc Dis. 2020;30(7):1121-1129.
de Larriva APArenas, Alonso A, Norby FL, Roetker NS. "Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study." J Thromb Haemost. 2019;17(5):818-826.
de Larriva APArenas, Norby FL, Chen LYee, et al. "Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study." Int J Cardiol. 2017;241:223-228.
Folsom AR, Yao L, Alonso A, et al. "Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2015;132(7):578-85.
Prizment AE, Linabery AM, Lutsey PL, et al. "Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)." Cancer Epidemiol Biomarkers Prev. 2016;25(4):657-64.
Hwang SJ, Ballantyne CM, Sharrett AR, et al. "Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study." Circulation. 1997;96(12):4219-25.
Ding N, Sang Y, Chen J, et al. "Cigarette Smoking, Smoking Cessation, and Long-Term Risk of 3 Major Atherosclerotic Diseases." J Am Coll Cardiol. 2019;74(4):498-507.
Ding N, Shah AM, Blaha MJ, Chang PP, Rosamond WD, Matsushita K. "Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction." J Am Coll Cardiol. 2022;79(23):2298-2305.
Howard G, Wagenknecht LE, Burke GL, et al. "Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study." JAMA. 1998;279(2):119-24.
Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF. "Cigarette smoking and other risk factors for silent cerebral infarction in the general population." Stroke. 1998;29(5):913-7.
Zhang L, Samet J, Caffo B, Punjabi NM. "Cigarette smoking and nocturnal sleep architecture." Am J Epidemiol. 2006;164(6):529-37.
Sonsin-Diaz N, Gottesman RF, Fracica E, Walston J, B Windham G, Knopman DS. "Chronic Systemic Inflammation Is Associated With Symptoms of Late-Life Depression: The ARIC Study." Am J Geriatr Psychiatry. 2020;28(1):87-98.
Sanders AE, Sofer T, Wong Q, et al. "Chronic Periodontitis Genome-wide Association Study in the Hispanic Community Health Study / Study of Latinos." J Dent Res. 2017;96(1):64-72.
Rhodin K, Divaris K, North KE, Barros SP, Moss K, Beck JD. "Chronic periodontitis genome-wide association studies: gene-centric and gene set enrichment analyses." J Dent Res. 2014;93(9):882-90.
Matsushita K, Kwak L, Ballew SH, et al. "Chronic kidney disease measures and the risk of abdominal aortic aneurysm." Atherosclerosis. 2018;279:107-113.
Lamprea-Montealegre JA, Sharrett ARichey, Matsushita K, Selvin E, Szklo M. "Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study." Atherosclerosis. 2014;234(1):42-6.
Alonso A, Lopez FL, Matsushita K, et al. "Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2011;123(25):2946-53.
Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. "Chronic kidney disease increases risk for venous thromboembolism." J Am Soc Nephrol. 2008;19(1):135-40.
Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M. "Chronic kidney disease and venous thromboembolism: a prospective study." Nephrol Dial Transplant. 2010;25(10):3296-301.
Ishigami J, Grams ME, Naik RP, Coresh JJ. "Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study." Clin J Am Soc Nephrol. 2016;11(10):1735-1743.
Luft VC, Schmidt MI, Pankow JS, Couper DJ, Ballantyne CM, Young HJ. "Chronic inflammation role in the obesity-diabetes association: a case-cohort study." Diabetol Metab Syndr. 2013;5(1):31.
Rubin J, Matsushita K, Ballantyne CM, Hoogeveen R, Coresh J, Selvin E. "Chronic hyperglycemia and subclinical myocardial injury." J Am Coll Cardiol. 2012;59(5):484-9.
Natarajan P, Pampana A, Graham SE, et al. "Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices." Nat Commun. 2021;12(1):2182.
Nieto FJ, Folsom AR, Sorlie PD, Grayston JT, Wang SP, Chambless LE. "Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 1999;150(2):149-56.
Wang QY, Song J, Gibbs RA, Boerwinkle E, Dong JF, Yu FL. "Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes." J Thromb Haemost. 2013;11(2):261-9.
Rathore SS, Hinn AR, Cooper LS, Tyroler HA, Rosamond WD. "Characterization of incident stroke signs and symptoms: findings from the atherosclerosis risk in communities study." Stroke. 2002;33(11):2718-21.
Bennett EE, Lynch KM, Xu X, et al. "Characteristics of movers and predictors of residential mobility in the Atherosclerosis Risk in Communities (ARIC) cohort." Health Place. 2022;74:102771.
Patel MD, Kalbaugh CA, Chang PP, et al. "Characteristics and outcomes of patients with acute decompensated heart failure developing after hospital admission." Am J Cardiol. 2014;114(10):1530-6.
Eigenbrodt ML, Fuchs FD, Couper DJ, et al. "Changing drinking pattern does not influence health perception: a longitudinal study of the atherosclerosis risk in communities study." J Epidemiol Community Health. 2006;60(4):345-50.
Ishigami J, Honda Y, Karger AB, et al. "Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study." Mayo Clin Proc Innov Qual Outcomes. 2022;6(3):209-217.
Folsom AR, McGovern PG, Nabulsi AA, et al. "Changes in plasma lipids and lipoproteins associated with starting or stopping postmenopausal hormone replacement therapy. Atherosclerosis Risk in Communities Study." Am Heart J. 1996;132(5):952-8.
Cowan LT, Tome J, Mallhi AKaur, et al. "Changes in physical activity and risk of ischemic stroke: The ARIC study." Int J Stroke. 2022:17474930221094221.
Foti K, Matsushita K, Koton S, et al. "Changes in hypertension control in a community-based population of older adults, 2011-2013 to 2016-2017." Am J Hypertens. 2020.
Stevens J, Cai J. "Changes in body mass index prior to baseline among participants who are ill or who die during the early years of follow-up." Am J Epidemiol. 2001;153(10):946-53.
Cobb LK, McAdams-Demarco MA, Gudzune KA, et al. "Changes in Body Mass Index and Obesity Risk in Married Couples Over 25 Years: The ARIC Cohort Study." Am J Epidemiol. 2016;183(5):435-43.
Peeters A, Magliano DJ, Stevens J, Duncan BB, Klein R, Wong TY. "Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study." Arch Ophthalmol. 2008;126(11):1554-60.
Rebholz CM, Grams ME, Matsushita K, Selvin E. "Change in novel filtration markers and risk of ESRD." Am J Kidney Dis. 2015;66(1):47-54.
Rebholz CM, Grams ME, Matsushita K, et al. "Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality." Clin J Am Soc Nephrol. 2015;10(6):941-8.
Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J. "Change in estimated GFR associates with coronary heart disease and mortality." J Am Soc Nephrol. 2009;20(12):2617-24.
Coresh JJ, Heerspink HJL, Sang Y, et al. "Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies." Lancet Diabetes Endocrinol. 2019;7(2):115-127.
Dadu RT, Dodge R, Nambi V, et al. "Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study." Circ Heart Fail. 2013;6(5):936-43.
Wong T Y, Klein R, A Sharrett R, et al. "Cerebral white matter lesions, retinopathy, and incident clinical stroke." JAMA. 2002;288(1):67-74.
Raina A, Zhao X, Grove ML, et al. "Cerebral white matter hyperintensities on MRI and acceleration of epigenetic aging: the atherosclerosis risk in communities study." Clin Epigenetics. 2017;9:21.
Johansen MC, Nyquist P, Sullivan KJ, Fornage M, Gottesman RF, Becker DM. "Cerebral Small-Vessel Disease in Individuals with a Family History of Coronary Heart Disease: The Atherosclerosis Risk in Communities Study." Neuroepidemiology. 2021;55(4):316-322.
Sargurupremraj M, Suzuki H, Jian X, et al. "Cerebral small vessel disease genomics and its implications across the lifespan." Nat Commun. 2020;11(1):6285.
Mosley TH, Knopman DS, Catellier DJ, et al. "Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study." Neurology. 2005;64(12):2056-62.
Palta P, Sharrett ARichey, Wei J, et al. "Central Arterial Stiffness Is Associated With Structural Brain Damage and Poorer Cognitive Performance: The ARIC Study." J Am Heart Assoc. 2019;8(2):e011045.
Meyer ML, Klein BE, Klein R, et al. "Central arterial stiffness and retinal vessel calibers: the Atherosclerosis Risk in Communities Study-Neurocognitive Study." J Hypertens. 2020;38(2):266-273.
Liu S, Kim ED, Wu A, et al. "Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults." PLoS One. 2019;14(2):e0212892.
Guo L, Akahori H, Harari E, et al. "CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis." J Clin Invest. 2018;128(3):1106-1124.
Vu KN, Ballantyne CM, Hoogeveen RC, Nambi V, Volcik KA, Boerwinkle E. "Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study." PLoS One. 2016;11(2):e0148765.
Yazdani A, Yazdani A. "A Causal Network Analysis of the Fatty Acid Metabolome in African-Americans Reveals a Critical Role for Palmitoleate and Margarate." OMICS. 2016;20(8):480-4.
Yazdani A, Yazdani A, Saniei A. "A causal network analysis in an observational study identifies metabolomics pathways influencing plasma triglyceride levels." Metabolomics. 2016;12:104.
Holmes MV, Lange LA, Palmer T, et al. "Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis." Am J Hum Genet. 2014;94(2):198-208.
Wuttke M, Li Y, Li M, et al. "A catalog of genetic loci associated with kidney function from analyses of a million individuals." Nat Genet. 2019;51(6):957-972.

Pages